| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/01/2004 | US20040128720 Preparing transgenic tomato, soybean, sugar cane and sorghum with increased growth and commercial yields when exposes to growth limiting condition |
| 07/01/2004 | US20040128719 Materials and methods for tissue-specific targeting of ethylene insensitivity in transgenic plants |
| 07/01/2004 | US20040128718 Plants containing a cytosolic acetyl CoA-carboxylase nucleic acid |
| 07/01/2004 | US20040128717 Modulating plant gene expression using tandem arrays of modular transcriptional factor binding units; gene expression and tissue engineering; biological pest control and disease resistant plants |
| 07/01/2004 | US20040128716 Transformation of plant cell with nucleotide sequences coding bacillus insecticidal protein generating insect resistant plants; biological pest control |
| 07/01/2004 | US20040128715 Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof |
| 07/01/2004 | US20040128714 Method of decreasing liquiritigenin-derived isoflavones relative to total isoflavones in plants and plants producing reduced ratio of liquiritigenin-derived isoflavones relative to total isoflavones |
| 07/01/2004 | US20040128713 Soybean plant producing seeds with reduced levels of raffinose saccharides and phytic acid |
| 07/01/2004 | US20040128712 Comprises nucleotide sequences coding plant transcription factor for transformation and propagation of osmotic stress resistant and disease resistant soybean, tomatoes and rice |
| 07/01/2004 | US20040128711 Methods and compositions for production of flavonoid and isoflavonoid nutraceuticals |
| 07/01/2004 | US20040128710 Novel polypeptides and polynucleotides relating to the alpha- and beta-subunits of glutamate dehydrogenases and methods of use |
| 07/01/2004 | US20040128709 Composite utilization of a group of genes in biosynthetic pathway of caffeine |
| 07/01/2004 | US20040128708 Transgenic rodent encoding nucleotide sequences coding melanin concentrating hormone type 1 receptor for use in treatment of sleep and eating disorders |
| 07/01/2004 | US20040128707 Animal model for pancreatic disorder associated with signal transduction; obesity prevention |
| 07/01/2004 | US20040128706 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 07/01/2004 | US20040128705 Stearoyl CoA desaturase transgenic non-human animals |
| 07/01/2004 | US20040128704 Using nucleotide sequences coding apoptosis interacting protein to transform and propagate plant cells; heterologous gene expression and control of nematode infection, dehiscence and stigma morphology |
| 07/01/2004 | US20040128703 DNA construct containing a human DNA sequence flanked by sequences from the non-human animal is generated by recombination in a bacterial cell, DNA construct that is produced can then be introduced into a non-human embryogenic stem cell |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127695 Plants toxic to coleopteran insects and Ctenocephalides Spp. |
| 07/01/2004 | US20040127694 Antisense IAP oligonucleotides and uses thereof |
| 07/01/2004 | US20040127686 Signal transduction regulator binding protein for identifying modulators for prevention and treatment of cardiomyopic hypertrophy, heart failure and diabetes; drug screening |
| 07/01/2004 | US20040127474 Contacting the cell with a ptc agonist in a sufficient amount to inhibit the altered growth state, wherein the ptc agonist is a organic molecule having a molecular weight less than about 750 amu for inhibiting an altered growth state of a cell |
| 07/01/2004 | US20040127451 strategy with which to derive treatments for hyperproliferative disorders, developmental disorders, inflammatory disorders, neural disorders and diseases arising from aberrant apoptosis |
| 07/01/2004 | US20040127450 the CCRG gene, a human gene associated with cancer, antisense oligonucleotides that decreases expression of said CCRG in conjunction with chemotherapeutic agent or a radiotherapy beam |
| 07/01/2004 | US20040127446 Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication |
| 07/01/2004 | US20040127441 Compositions and Methods for Treatment of Prostate and Other Cancers |
| 07/01/2004 | US20040127438 polypeptide (or its encoding nucleic acid molecule from Mycobacterium tuberculosis or related prokaryotes in the treatment of cancer, allergic disorders or conditions of immunoactivation, particularly asthma |
| 07/01/2004 | US20040127419 Methods of using truncated glial cell line-derived neurotrophic factor |
| 07/01/2004 | US20040127410 Circular permuteins of flt3 ligand |
| 07/01/2004 | US20040127401 CA125 gene and its use for diagnostic and therapeutic interventions |
| 07/01/2004 | US20040126887 Mixture comprising cationic proteins, lipids and polyethylenimine for use in enhancing transpoase mediated DNA genome integration; genetic engineering and gene expression analysis |
| 07/01/2004 | US20040126885 Delivery vehicle for recombinant proteins |
| 07/01/2004 | US20040126883 Method for producing a multi-gene recombinant vector construct and the application |
| 07/01/2004 | US20040126882 Transforming cells with plasmid containing catalytic nucleotide sequences and using catalytic entity to control transcriptional expression of heterologus genes |
| 07/01/2004 | US20040126873 Cells engineered to contain genes of interest |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126869 Method of producing infectious reovirus |
| 07/01/2004 | US20040126866 Comprises nucleotide sequences coding cyclic nucleotide phosphodiesterases for treatment of cardiovascular, depressive and vascular disorders; cardiotonic agents; antidepressants; antihypertensives; antithrombotics |
| 07/01/2004 | US20040126863 Comprises amino acid sequences for use in identifying modulators for diagnosis and treatment of respiratory and diabetes-induced peripheral vascular diseases; mimetics |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126859 Mutant forms of Fas ligand and uses thereof |
| 07/01/2004 | US20040126858 Comprises enzymatic polypeptide for use in identification of modulators for prevention and treatment of free radical damage, inflammatory, metabolic and cancer disorders |
| 07/01/2004 | US20040126857 novel enzymes that can reduce 4-haloacetoacetic acid esters using NADH as a coenzyme and produce (S)-4-halo-3-hydroxybutyric acid esters having high optical purities |
| 07/01/2004 | US20040126854 Generation of transgenic microorganism coding enzymatic polypeptide with enhanced capabilities associated with lysine biosynthesis; improving animal feeds, cosmetics and pharmeceutical agents |
| 07/01/2004 | US20040126850 Directed evolution of protein in Mammalian cells |
| 07/01/2004 | US20040126848 Preparing methylomonas regulatory sequence for use in the expression of heterologous sequences and protein in methanotrophs; carotenoid biosynthesis |
| 07/01/2004 | US20040126847 Preparing transgenic coryneform bacterium capable of expressing industrially useful heterologous proteins such as transglutaminase; bioreactors |
| 07/01/2004 | US20040126845 Nucleotide sequences comprising regulatory elements which simultaneously enhance the expression of a first RNA sequence and at the same time as suppress the expression of a second RNA sequences; gene expression inhibition |
| 07/01/2004 | US20040126843 Comprises nucleotide sequences coding polypeptide which regulate flower expression; improving nutrient quality of feeds for ruminant animals |
| 07/01/2004 | US20040126842 Mutant E. coli strains, and their use for producing recombinant polypeptides |
| 07/01/2004 | US20040126841 Novel G-protein coupled receptor, HLTEX11 |
| 07/01/2004 | US20040126839 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/01/2004 | US20040126824 Ovarian cancer-specific promoter |
| 07/01/2004 | US20040126817 Identifying modulators of cell surface channel proteins; prevention and treatment of cell proliferative, skin and hearing disorders |
| 07/01/2004 | US20040126816 Using blood coagulation factor to identify antibodies which modulate, prevent and treat tumors, inflammation, septic shock, hypotension and adult respiratory distress syndrome |
| 07/01/2004 | US20040126801 Novel polynucleotides and encoded polypeptides |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126796 Extraction of DNA from biological samples |
| 07/01/2004 | US20040126791 Compositions and methods for treating trail-resistant cancer cells |
| 07/01/2004 | US20040126785 Metastatic colon cancer specific promoter and uses thereof |
| 07/01/2004 | US20040126783 Apparatus and method for isolating a nucleic acid from a sample |
| 07/01/2004 | US20040126782 System and method for SNP genotype clustering |
| 07/01/2004 | US20040126778 Isolation of dna molecules |
| 07/01/2004 | US20040126776 Gene library and a method for producing the same |
| 07/01/2004 | US20040126774 Correction of factor VIII genetic defects using spliceosome mediated RNA trans splicing |
| 07/01/2004 | US20040126771 PRNA chimera |
| 07/01/2004 | US20040126770 Rolling circle amplification of RNA |
| 07/01/2004 | US20040126768 Selection procedure for identifying transgenic cells, embryos, and plants without the use of antibiotics |
| 07/01/2004 | US20040126761 Modulation of alpha-methylacyl-CoA racemase expression |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126758 homologous to the known fibrinogen derived haptotactic peptides; shown to elicit activity from fibroblasts, endothelial and smooth muscle cells; for wound healing and enhancing osteogenesis/angiogenesis in vivo with/without medical implant |
| 07/01/2004 | US20040126756 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 07/01/2004 | US20040126754 reacting with the majority of anti-HCV antibodies present in patient sera; bioassays; solid phase synthesis; kits |
| 07/01/2004 | US20040126753 Process for producing viral rna polymerase |
| 07/01/2004 | US20040126395 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 07/01/2004 | US20040126391 Meningococcal antigens |
| 07/01/2004 | US20040126390 Recombinant plasmid and a method of controlling the effects of Yersinia pestis |
| 07/01/2004 | US20040126388 Measurement genome reproduction of virus; linked to reproter compound; high speed screening for Hepatitis virus |
| 07/01/2004 | US20040126382 Two-step immunization procedure against chlamydia infection |
| 07/01/2004 | US20040126364 Antiinflammatory agents; genetic engineered interleukins; oral diseases |
| 07/01/2004 | US20040126363 Cd19-specific redirected immune cells |
| 07/01/2004 | US20040126359 Modulate lymphocyte activation; cell proliferation; apoptosis; signal transduction |
| 07/01/2004 | DE10258971A1 Use of astaxanthin-containing plant material, or extracts, from Tagetes for oral administration to animals, particularly for pigmentation of fish, crustacea, birds and their products |
| 07/01/2004 | DE10257479A1 Optimierte Proteinsynthese Optimized protein synthesis |
| 07/01/2004 | CA2840513A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 07/01/2004 | CA2808592A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 07/01/2004 | CA2808584A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 07/01/2004 | CA2808318A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 07/01/2004 | CA2808190A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 07/01/2004 | CA2807515A1 Alphavirus particles and methods for preparation |
| 07/01/2004 | CA2779684A1 Immunization of fish with plant-expressed recombinant proteins |
| 07/01/2004 | CA2510184A1 In vivo affinity maturation scheme |
| 07/01/2004 | CA2510179A1 A method for improving protein production |
| 07/01/2004 | CA2510049A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 07/01/2004 | CA2509979A1 Alphavirus particles and methods for preparation |
| 07/01/2004 | CA2509973A1 Multi-antigenic alphavirus replicon particles and methods |
| 07/01/2004 | CA2509832A1 Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor |
| 07/01/2004 | CA2509827A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 07/01/2004 | CA2509694A1 Ftsz-polypeptides as a target for herbicidal compounds |